1054624-77-9

White Solid

Labeled Ranolazine, intended for use as an internal standard for the quantification of Ranolazine by GC- or LC-mass spectrometry.

Ranolazine is an anti-ischemic agent which modulates myocardial metabolism. Antianginal.

Ranolazine-d3 is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor.